Quantification of Change in MG Disease Activity in Individuals With Generalized Myasthenia Gravis (gMG) After Administration of VYVGART® or VYVGART Hytrulo® Using BioDigit MG
Clinical trial NCT07226830 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07226830
- Sponsor
- BioSensics
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-15
- Primary completion
- 2028-01-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.